Literature DB >> 1569094

Molecular diversity in amino-terminal domains of human calpastatin by exon skipping.

W J Lee1, H Ma, E Takano, H Q Yang, M Hatanaka, M Maki.   

Abstract

Calpastatin, a specific inhibitor of calpain, consists of a unique N-terminal domain (domain L) and four repetitive calpain-inhibition domains (domains 1-4). Calpastatin cDNA of human was reported to have two deletions in domains L and 1, as compared with that of pig and rabbit. We isolated human calpastatin genomic DNA clones, and the sequence analysis revealed seven exons for domain L and five exons for domain 1. Those deletions in the human cDNA were retained in its genomic DNA as exons 3 and 11. By the reverse transcription polymerase chain reaction method, three calpastatin cDNAs, full-length domains L and 1, and two natural mutants with deletions in either exon 3 or in both exons 3 and 5, were cloned from human fibroblast WI-38 cell line mRNA. Domain L was found to be rich in basic amino acid residues, especially for exon 3, and its N-terminal half was highly conserved among species. The isoelectric points (pI) of domain L and domains 1-4 were calculated to be 10.27 and 4.26-4.90, respectively. Moreover, human tissues and cell lines displayed different patterns of reverse transcription polymerase chain reaction products in agarose gel electrophoresis. Therefore, alternative splicing is most likely the cause for the molecular diversity, and the multiple isoforms are implicated for specific physiological roles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569094

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Changes in intracellular calpastatin localization are mediated by reversible phosphorylation.

Authors:  M Averna; R de Tullio; M Passalacqua; F Salamino; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

2.  Calpastatin domain L is a partial agonist of the calmodulin-binding site for channel activation in Cav1.2 Ca2+ channels.

Authors:  Etsuko Minobe; Hadhimulya Asmara; Zahangir A Saud; Masaki Kameyama
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

4.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

5.  Heritability of alternative splicing in the human genome.

Authors:  Tony Kwan; David Benovoy; Christel Dias; Scott Gurd; David Serre; Harry Zuzan; Tyson A Clark; Anthony Schweitzer; Michelle K Staples; Hui Wang; John E Blume; Thomas J Hudson; Rob Sladek; Jacek Majewski
Journal:  Genome Res       Date:  2007-08       Impact factor: 9.043

6.  v-Src-induced modulation of the calpain-calpastatin proteolytic system regulates transformation.

Authors:  N O Carragher; M A Westhoff; D Riley; D A Potter; P Dutt; J S Elce; P A Greer; M C Frame
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 7.  The calpain system and cancer.

Authors:  Sarah J Storr; Neil O Carragher; Margaret C Frame; Tim Parr; Stewart G Martin
Journal:  Nat Rev Cancer       Date:  2011-05       Impact factor: 60.716

Review 8.  Structure and physiological function of calpains.

Authors:  H Sorimachi; S Ishiura; K Suzuki
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

9.  Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells.

Authors:  Bei Fei; Shuai Yu; Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2013-05-16

10.  Calpain regulates actin remodeling during cell spreading.

Authors:  D A Potter; J S Tirnauer; R Janssen; D E Croall; C N Hughes; K A Fiacco; J W Mier; M Maki; I M Herman
Journal:  J Cell Biol       Date:  1998-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.